Barcelona, Spain

Marc Suñé Pou

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Intas Pharmaceuticals Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marc Suñé Pou. Retrieved from https://idiyas.com/inventor/marc-suñé-pou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Marc Suñé Pou: Pharmaceutical Formulation Inventor.

Introduction

Marc Suñé Pou is an inventor associated with Barcelona, Spain, and Intas Pharmaceuticals Limited. His work includes a patent for an effervescent pharmaceutical formulation designed to contain very little sodium.

Latest Patents

The supplied information identifies one patent associated with Suñé Pou: “Essentially Sodium-Free Effervescent Solid Pharmaceutical Compositions.” The invention describes a solid effervescent pharmaceutical composition containing an active pharmaceutical ingredient, alkaline earth metal carbonates or hydrogencarbonates, and pharmaceutically acceptable acids or acid salts. It specifies that the composition’s total sodium-ion content is no more than 1 mmol. The patent also addresses preparation processes and therapeutic use. The supplied record lists 1 patent.

Career Highlights

Suñé Pou’s listed patent focuses on pharmaceutical formulation, particularly the development of effervescent medicines with substantially reduced sodium content. The supplied information associates him with Intas Pharmaceuticals Limited.

Collaborations

The listed coworkers are José María Suñé Negre and Xavier Formosa Márquez. Their names are provided as collaborators in the supplied information.

Conclusion

Marc Suñé Pou’s listed invention addresses the formulation and therapeutic use of essentially sodium-free effervescent medicines, reflecting a focused contribution to pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…